276 related articles for article (PubMed ID: 2575468)
1. Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease.
Marcocci C; Vitti P; Lopez G; Santini F; Mammoli C; Fenzi GF; Pinchera A
Clin Endocrinol (Oxf); 1989 Feb; 30(2):109-19. PubMed ID: 2575468
[TBL] [Abstract][Full Text] [Related]
2. Graves' IgG stimulation of iodide uptake in FRTL-5 rat thyroid cells: a clinical assay complementing FRTL-5 assays measuring adenylate cyclase and growth-stimulating antibodies in autoimmune thyroid disease.
Marcocci C; Valente WA; Pinchera A; Aloj SM; Kohn LD; Grollman EF
J Endocrinol Invest; 1983 Dec; 6(6):463-71. PubMed ID: 6689493
[TBL] [Abstract][Full Text] [Related]
3. Use of FRTL-5 for the study of thyroid antibodies involved in goitrogenesis.
Vitti P; Chiovato L; Tonacchera M; Bendinelli G; Mammoli C; Capaccioli A; Giachetti M; Pinchera A
Thyroidology; 1992 Apr; 4(1):49-51. PubMed ID: 1284334
[TBL] [Abstract][Full Text] [Related]
4. Evidence supporting the identity in Graves' disease of thyroid-stimulating antibody and thyroid growth-promoting immunoglobulin G as assayed in FRTL5 cells.
Zakarija M; Jin S; McKenzie JM
J Clin Invest; 1988 Mar; 81(3):879-84. PubMed ID: 2893811
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of blocking immunoglobulins G, having a heterogeneous behaviour, in sera of patients with Graves' disease: possible coexistence of different autoantibodies directed to the TSH receptor.
Macchia E; Concetti R; Carone G; Borgoni F; Fenzi GF; Pinchera A
Clin Endocrinol (Oxf); 1988 Feb; 28(2):147-56. PubMed ID: 2901922
[TBL] [Abstract][Full Text] [Related]
6. Stimulated iodide uptake in FRTL-5 cells preincubated with Graves' immunoglobulins in NaCl-free medium: a sensitive assay for thyroid-stimulating antibodies.
Hidaka A; Kasagi K; Takeuchi R; Iida Y; Misaki T; Grollman EF; Konishi J
Thyroid; 1994; 4(1):31-6. PubMed ID: 7914446
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
8. Measurement of thyroid-stimulating immunoglobulins by incorporation of tritiated-adenine into intact FRTL-5 cells: a viable alternative to radioimmunoassay for the measurement of cAMP.
Leedman PJ; Frauman AG; Colman PG; Michelangeli VP
Clin Endocrinol (Oxf); 1992 Dec; 37(6):493-9. PubMed ID: 1363083
[TBL] [Abstract][Full Text] [Related]
9. Detection of thyroid-stimulating antibody using Chinese hamster ovary cells transfected with cloned human thyrotropin receptor.
Vitti P; Elisei R; Tonacchera M; Chiovato L; Mancusi F; Rago T; Mammoli C; Ludgate M; Vassart G; Pinchera A
J Clin Endocrinol Metab; 1993 Feb; 76(2):499-503. PubMed ID: 8094393
[TBL] [Abstract][Full Text] [Related]
10. Measurement of thyroid stimulating immunoglobulins in a new cell line transfected with a functional human TSH receptor (JPO9 cells), compared with an assay using FRTL-5 cells.
Michelangeli VP; Munro DS; Poon CW; Frauman AG; Colman PG
Clin Endocrinol (Oxf); 1994 May; 40(5):645-52. PubMed ID: 7912172
[TBL] [Abstract][Full Text] [Related]
11. Failure to detect thyroid growth-promoting activity in immunoglobulin G of patients with endemic goiter.
Vitti P; Chiovato L; Tonacchera M; Bendinelli G; Mammoli C; Capaccioli A; Fiore E; Pretell E; Pinchera A
J Clin Endocrinol Metab; 1994 May; 78(5):1020-5. PubMed ID: 7909816
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay.
Vitti P; Rotella CM; Valente WA; Cohen J; Aloj SM; Laccetti P; Ambesi-Impiombato FS; Grollman EF; Pinchera A; Toccafondi R; Kohn LD
J Clin Endocrinol Metab; 1983 Oct; 57(4):782-91. PubMed ID: 6136523
[TBL] [Abstract][Full Text] [Related]
13. Use of cells expressing the human thyrotropin (TSH) receptor for the measurement of thyroid stimulating and TSH-blocking antibodies.
Vitti P; Chiovato L; Fiore E; Mammoli C; Rocchi R; Pinchera A
Acta Med Austriaca; 1996; 23(1-2):52-6. PubMed ID: 8767515
[TBL] [Abstract][Full Text] [Related]
14. Interactions between TSH binding inhibiting--and adenylate cyclase stimulating--antibodies in Graves' disease.
Morita S; Izumi M; Nagataki S
Acta Endocrinol (Copenh); 1986 Aug; 112(4):517-22. PubMed ID: 2875588
[TBL] [Abstract][Full Text] [Related]
15. Activity of thyroid stimulating antibody and thyroid stimulation blocking antibody determined by radioiodine uptake into FRTL-5 cells.
Yoshikawa N; Nishikawa M; Horimoto M; Uno C; Taniguchi N; Inada M
Endocrinol Jpn; 1989 Feb; 36(1):55-63. PubMed ID: 2567231
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of TSH receptor antibody by 'natural in vivo human assay' in neonates born to mothers with Graves' disease.
Tamaki H; Amino N; Iwatani Y; Tachi J; Kimura M; Mitsuda N; Ichihara K; Tanizawa O; Miyai K
Clin Endocrinol (Oxf); 1989 May; 30(5):493-503. PubMed ID: 2575017
[TBL] [Abstract][Full Text] [Related]
17. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease.
Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K
J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336
[TBL] [Abstract][Full Text] [Related]
18. Measurement of TSAb directly in serum using FRTL-5 cells.
Vitti P; Chiovato L; Lopez G; Lombardi A; Santini F; Mammoli C; Bassi P; Gryczynska M; Schipani E; Tosti-Balducci M
J Endocrinol Invest; 1988 Apr; 11(4):313-7. PubMed ID: 2900851
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of parallel measurements of thyrotropin binding inhibiting immunoglobulins (TBII) and thyroid adenylate cyclase stimulating antibodies (TSAb) in Graves' disease after longterm antithyroid treatment.
Bliddal H; Bech K; Siersbaek-Nielsen K; Friis T
J Endocrinol Invest; 1983 Aug; 6(4):259-62. PubMed ID: 6139399
[TBL] [Abstract][Full Text] [Related]
20. A sensitive method for assaying thyroid stimulating immunoglobulins of Graves' disease: use of the guanyl nucleotide-amplified thyroid adenylate cyclase assay.
Macchia E; Carayon P; Fenzi GF; Lissitzky S; Pinchera A
Acta Endocrinol (Copenh); 1983 Jul; 103(3):345-51. PubMed ID: 6688318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
